Zyprexa, Risperdal and Seroquel are less effective, yet more expensive
A study funded by the British government found that newer atypical antipsychotics (Zyprexa, Risperdal and Seroquel) could be less effective in treating schizophrenia, even though they are more expensive than older medications. The study calls into question why doctors are increasingly prescribing these newer atypical antipsychotics.
The Washington Post reported on this study and indicated that many experts believe aggressive marketing of these drugs by the pharmaceutical companies has contributed to a perception that they are more effective, even though there is no empirical evidence supporting that.
The British study was funded to determine whether Zyprexa, Risperdal and Seroquel are worth the increased cost when compared to older medications. These atypical antipsychotics can cost ten times more, yet the study found they are no more effective than older psychiatric drugs for treatment of schizophrenia.
Recently Zyprexa, Risperdal and Seroquel Lawsuits have been filed across the country for side effects causing diabetes. Saiontz & Kirk is currently representing individuals who have been injured by the atypical antipsychotics’ side effects.
If further research confirms that these more expensive drugs are no more effective, we will likely start to see lawsuits filed by health insurers and governments to recoup benefits paid for these prescription medications.
